Search Results - "Kollman, C."

Children and adolescents with type 1 and type 2 diabetes mellitus in the Pediatric Diabetes Consortium Registries: comparing clinical characteristics and glycaemic control by Van Name, M. A., Cheng, P., Gal, R. L., Kollman, C., Lynch, J., Nelson, B., Tamborlane, W. V.

“…Aim To compare the characteristics of children and adolescents with type 1 vs. type 2 diabetes in the Pediatric Diabetes Consortium (PDC) registries. Methods…”
Get full text

Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes by Tansey, M., Laffel, L., Cheng, J., Beck, R., Coffey, J., Huang, E., Kollman, C., Lawrence, J., Lee, J., Ruedy, K., Tamborlane, W., Wysocki, T., Xing, D.

“…Diabet. Med. 28, 1118–1122 (2011) Aims  To describe satisfaction with continuous glucose monitoring in Type 1 diabetes; to correlate continuous glucose…”
Get full text

Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial by Elleri, D., Biagioni, M., Allen, J. M., Kumareswaran, K., Leelarathna, L., Caldwell, K., Nodale, M., Wilinska, M. E., Haidar, A., Calhoun, P., Kollman, C., Jackson, N. C., Umpleby, A. M., Acerini, C. L., Dunger, D. B., Hovorka, R.

“…Aims To evaluate safety, efficacy and glucose turnover during closed‐loop with meal announcement using reduced prandial insulin boluses in adolescents with…”
Get full text

Safety of closed-loop therapy during reduction or omission of meal boluses in adolescents with type 1 diabetes: a randomized clinical trial by Elleri, D., Maltoni, G., Allen, J. M., Nodale, M., Kumareswaran, K., Leelarathna, L., Thabit, H., Caldwell, K., Wilinska, M. E., Calhoun, P., Kollman, C., Dunger, D. B., Hovorka, Roman

“…We evaluated the safety and efficacy of closed‐loop therapy with meal announcement during reduction and omission of meal insulin boluses in adolescents with…”
Get full text

Ten-year follow-up of the ‘minimal MRI lesion’ subgroup from the original CHAMPS Multiple Sclerosis Prevention Trial by Simon, JH, Kinkel, RP, Kollman, C, O’Connor, P, Fisher, E, You, X, Hyde, R

“…Background: Patients with clinically isolated syndrome (CIS) and characteristic magnetic resonance imaging (MRI) lesions are at high risk for multiple…”
Get full text

Persistently high glucose levels in young children with type 1 diabetes by Tansey, M, Beck, R, Ruedy, K, Tamborlane, W, Cheng, P, Kollman, C, Fox, L, Weinzimer, S, Mauras, N, White, NH, Tsalikian, E

“…Objectives The aim of the study was to characterize glucose levels and variability in young children with type 1 diabetes (T1D). Methods A total of 144…”
Get full text

A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes by Breton, Marc D, Kanapka, Lauren G, Beck, Roy W, Ekhlaspour, Laya, Forlenza, Gregory P, Cengiz, Eda, Schoelwer, Melissa, Ruedy, Katrina J, Jost, Emily, Carria, Lori, Emory, Emma, Hsu, Liana J, Oliveri, Mary, Kollman, Craig C, Dokken, Betsy B, Weinzimer, Stuart A, DeBoer, Mark D, Buckingham, Bruce A, Cherñavvsky, Daniel, Wadwa, R. Paul

“…A closed-loop system (also called an artificial pancreas) may improve glycemic outcomes in children with type 1 diabetes. In this 16-week trial, the glucose…”
Get full text

Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia by Uberti, J P, Agovi, M-A, Tarima, S, Haagenson, M, Gandham, S, Anasetti, C, Baker, K S, Bolwell, B J, Bornhauser, M, Chan, K W, Copelan, E, Davies, S M, Finke, J, Hale, G A, Kollman, C, McCarthy, P L, Ratanatharathorn, V, Ringdén, O, Weisdorf, D J, Rizzo, J D

“…We retrospectively compared clinical outcomes in 1593 T-replete unrelated donor (URD) marrow transplant recipients with AML, MDS and CML who received…”
Get full text

Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control System by Schoelwer, Melissa J, Kanapka, Lauren G, Wadwa, R Paul, Breton, Marc D, Ruedy, Katrina J, Ekhlaspour, Laya, Forlenza, Gregory P, Cobry, Erin C, Messer, Laurel H, Cengiz, Eda, Jost, Emily, Carria, Lori, Emory, Emma, Hsu, Liana J, Weinzimer, Stuart A, Buckingham, Bruce A, Lal, Rayhan A, Oliveri, Mary Clancy, Kollman, Craig C, Dokken, Betsy B, Cherñavvsky, Daniel R, Beck, Roy W, DeBoer, Mark D

“…Studies of closed-loop control (CLC) in patients with type 1 diabetes (T1D) consistently demonstrate improvements in glycemic control as measured by increased…”
Get more information

FP39-WE-04 CHAMPIONS extension: 10-year outcomes in interferon beta-1a-treated patients at high risk for developing multiple sclerosis after a clinically isolated syndrome by Putzki, N, Kinkel, R.P, Dontchev, M, Tanner, J.P, Kollman, C, Simon, J, O'Connor, P, Hyde, R

Get full text

Outcome of unrelated transplants in patients with multiple myeloma by BALLEN, K. K, KING, R, CARSTON, M, KOLLMAN, C, NELSON, G, LIM, S, REECE, D, GIRALT, S, VESOLE, D. H

“…The outcome of patients with multiple myeloma treated with standard therapy is disappointing, with a historical median survival of 3 years. Although high-dose…”
Get full text

Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes by Ware, Julia, Allen, Janet M, Boughton, Charlotte K, Wilinska, Malgorzata E, Hartnell, Sara, Thankamony, Ajay, de Beaufort, Carine, Schierloh, Ulrike, Fröhlich-Reiterer, Elke, Mader, Julia K, Kapellen, Thomas M, Rami-Merhar, Birgit, Tauschmann, Martin, Nagl, Katrin, Hofer, Sabine E, Campbell, Fiona M, Yong, James, Hood, Korey K, Lawton, Julia, Roze, Stephane, Sibayan, Judy, Bocchino, Laura E, Kollman, Craig, Hovorka, Roman

“…In a multicenter, randomized, crossover trial involving children 1 to 7 years of age with type 1 diabetes, a closed-loop system was compared with…”
Get full text

Home Use of an Artificial Beta Cell in Type 1 Diabetes by Thabit, Hood, Tauschmann, Martin, Allen, Janet M, Leelarathna, Lalantha, Hartnell, Sara, Wilinska, Malgorzata E, Acerini, Carlo L, Dellweg, Sibylle, Benesch, Carsten, Heinemann, Lutz, Mader, Julia K, Holzer, Manuel, Kojzar, Harald, Exall, Jane, Yong, James, Pichierri, Jennifer, Barnard, Katharine D, Kollman, Craig, Cheng, Peiyao, Hindmarsh, Peter C, Campbell, Fiona M, Arnolds, Sabine, Pieber, Thomas R, Evans, Mark L, Dunger, David B, Hovorka, Roman

“…In two randomized trials conducted under home conditions, investigators compared closed-loop insulin delivery with sensor-augmented pump therapy in adults and…”
Get full text

Non-HLA barriers to unrelated donor stem cell transplantation by KOLLMAN, C, WEIS, T, SWITZER, G. E, HALET, M, KITAJIMA, D, HEGLAND, J, CONFER, D. L

“…A prospective survey involving 544 searches of the US National Marrow Donor Program (NMDP) Registry was conducted to identify reasons why many patients who…”
Get full text

The extent of HLA class II allele level disparity in unrelated bone marrow transplantation : analysis of 1259 National Marrow Donor Program donor-recipient pairs by HURLEY, C. K, BAXTER-LOWE, L. A, YUNIS, E. J, KITAJIMA, D, SHIPP, K, SPLETT, J, WINDEN, T, KOLLMAN, C, JOHNSON, D, NG, J, HARTZMAN, R. J, HEGLAND, J, BEGOVICH, A. B, FERNANDEZ-VINA, M, NOREEN, H, SCHMECKPEPER, B, AWDEH, Z, CHOPCK, M, SALAZAR, M, WILLIAMS, T. M

“…A comprehensive analysis of the HLA-D region loci, DRB1, DRB3, DRB5, DQA1, DQB1, DPA1 and DPB1, was performed to determine allelic diversity and underlying HLA…”
Get full text

The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens by Schreuder, G.M.Th, Hurley, C.K., Marsh, S.G.E., Lau, M., Maiers, M., Kollman, C., Noreen, H.J.

“…This report presents the serologic equivalents of 123 HLA-A, 272 HLA-B, and 155 HLA-DRB1 alleles. The equivalents cover over 64 percent of the presently…”
Get full text

Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies by Hovorka, Roman, Kumareswaran, Kavita, Harris, Julie, Allen, Janet M, Elleri, Daniela, Xing, Dongyuan, Kollman, Craig, Nodale, Marianna, Murphy, Helen R, Dunger, David B, Amiel, Stephanie A, Heller, Simon R, Wilinska, Malgorzata E, Evans, Mark L

“…Objective To compare the safety and efficacy of overnight closed loop delivery of insulin (artificial pancreas) with conventional insulin pump therapy in…”
Get full text

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome by Flomenberg, Neal, Baxter-Lowe, Lee Ann, Confer, Dennis, Fernandez-Vina, Marcelo, Filipovich, Alexandra, Horowitz, Mary, Hurley, Carolyn, Kollman, Craig, Anasetti, Claudio, Noreen, Harriet, Begovich, Ann, Hildebrand, William, Petersdorf, Effie, Schmeckpeper, Barbara, Setterholm, Michelle, Trachtenberg, Elizabeth, Williams, Thomas, Yunis, Edmond, Weisdorf, Daniel

“…Outcome of unrelated donor marrow transplantation is influenced by donor-recipient matching for HLA. Prior studies assessing the effects of mismatches at…”
Get full text

The HLA dictionary 1999: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens by Schreuder, G.M.Th, Hurley, C.K., Marsh, S.G.E., Lau, M., Maiers, M., Kollman, C., Noreen, H.

“…This report presents serologic equivalents of 90 HLA-A, 190 HLA-B, and 145 HLA-DRB1 alleles. The equivalents cover over 70% of the presently identified HLA-A,…”
Get full text

Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial by Ware, Julia, Boughton, Charlotte K, Allen, Janet M, Wilinska, Malgorzata E, Tauschmann, Martin, Denvir, Louise, Thankamony, Ajay, Campbell, Fiona M, Wadwa, R Paul, Buckingham, Bruce A, Davis, Nikki, Besser, Rachel E J, Weinzimer, Stuart A, Hood, Korey K, Kanapka, Lauren, Kollman, Craig, Beck, Roy W, Hovorka, Roman, Hovorka, R, Thankamony, A, Allen, J M, Boughton, C K, Dunger, D B, Ware, J, Musolino, G, Wilinska, M E, Hayes, J F, Slegtenhorst, S, Ruan, Y, Haydock, M, Mangat, J, Denvir, L, Law, J, Sachdev, P, Saxton, M, Stafford, S, Keeton, R, Cresswell, R, Fazackerley, H, Looby, L, Saddington, C, Smith, V, Verhoeven, V, Bratt, S, Khan, N, Moyes, L, Sandhu, K, West, C, Wadwa, R P, Alonso, G, Forlenza, G, Escobar, E, Jost, E, Messer, L, Campbell, F M, Yong, J, Metcalfe, E, Allen, M, Waheed, S, Exall, J, Tulip, J, Buckingham, B A, Norlander, L, Jacobson, T, Twon, M, Leverenz, B, Keller, J, Dewar, H, Mauras, N, Benson, M, Bird, K, Englert, K, Permuy, J, Ponthieux, K, DiMeglio, L A, Ismail, H, Besser, R EJ, London, R, Ryan, F, Bowen-Morris, J, Law, R, Deakin, M, Phelan, K, Cengiz, E, Van Name, M, Steffen, A, Zgorski, M, Davis, J, Hellman, A, Kanapka, L, McCarthy, C, Chalasani, S, Lanning, M, Eggerman, T, Janicek, R, Gabrielson, D, Castle, J, Green, J, Legault, L, Wysham, C

“…Closed-loop insulin delivery systems have the potential to address suboptimal glucose control in children and adolescents with type 1 diabetes. We compared…”
Get full text